LawPlayer
My bookmarksSign up freeSign up free
Source

Commission Implementing Regulation (EU) 2019/637 of 23 April 2019 approving cholecalciferol as an active substance for use in biocidal products of product-type 14 (Text with EEA relevance.)

Commission Implementing Regulation (EU) 2019/637 of 23 April 2019 approving cholecalciferol as an active substance for use in biocidal products of product-type 14 (Text with EEA relevance.)

Implementing Regulation (EU) 2019/637 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Cholecalciferol is approved as an active substance for use in biocidal products of product-type 14, subject to the specifications and conditions set out in the Annex.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Common Name IUPAC Name Identification Numbers Minimum degree of purity of the active substance  ( 1 ) Date of approval Expiry date of approval Product type Specific conditions Cholecalciferol IUPAC Name: (3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol EC No: 200-673-2 CAS No: 67-97-0 970 g/kg 1 July 2019 30 June 2024 14 Cholecalciferol is considered a candidate for substitution in accordance with points (a) and (e) of Article 10(1) of Regulation (EU) No 528/2012. The authorisations of biocidal products are subject to the following general conditions: (1) The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance. In addition, pursuant to point 10 of Annex VI to Regulation (EU) No 528/2012, the product assessment shall include an evaluation as to whether the conditions of Article 5(2) of Regulation (EU) No 528/2012 can be satisfied. (2) Products shall only be authorised for use in Member States where at least one of the conditions set out in Article 5(2) of Regulation (EU) No 528/2012 is satisfied. (3) According to point (d) of Article 19(4) of Regulation (EU) No 528/2012, products shall not be authorised for making available on the market for use by the general public. (4) The nominal concentration of cholecalciferol in the products shall not exceed 0,075 % w/w. (5) Products shall contain an aversive agent and a dye. (6) Products shall not be authorised in the form of tracking powder. (7) Products in the form of contact formulations, other than tracking powder, shall only be authorised for use by trained professionals indoors in places not accessible to children or non-target animals. (8) Only ready-to-use products shall be authorised. (9) Primary as well as secondary exposure of humans, non-target animals and the environment shall be minimised, by considering and applying all appropriate and available risk mitigation measures. They include for example the restriction to professional or trained professional use when possible and setting additional specific conditions per user category. (10) Dead bodies and uneaten bait shall be disposed of in accordance with local requirements. The method of disposal shall be described specifically in the summary of the product characteristics of the national authorisation and be reflected on the product label. In addition to the general conditions, the authorisations of biocidal products to be used by trained professionals are subject to the following conditions: (1) Products may be authorised for use in sewers, open area or waste dumps. (2) Products may be authorised for use in covered and protected bait points as long as they provide the same level of protection for non-target species and humans as tamper-resistant bait stations. (3) Products may only be authorised for use in permanent treatments at sites with a high potential for reinvasion when other methods of control have proven insufficient. (4) Products shall not be authorised for use in pulse baiting treatments. (5) Persons making available on the market products for trained professional users shall make sure that those products are not supplied to other persons than trained professionals. In addition to the general conditions, the authorisations of biocidal products to be used by professionals are subject to the following conditions: (1) Products shall not be authorised for use in sewers, open area or waste dumps. (2) Products shall not be authorised for use as a permanent bait or pulse baiting treatments. (3) Products shall only be authorised for use in tamper-resistant bait stations. (4) Persons making available on the market products for professional users shall make sure that those products are not supplied to the general public. ( 1 )   The purity indicated in this column was the minimum degree of purity of the active substance evaluated. The active substance in the product placed on the market can be of equal or different purity if it has been proven to be technically equivalent to the evaluated active substance.

Other acts of the same type
Commission Regulation (EU) 2024/891 of 22 March 2024 amending Annexes II and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for bifenazate in or on certain productsCommission Implementing Regulation (EU) 2024/892 of 22 March 2024 designating European Union reference laboratories for certain specific areas of public healthCommission Implementing Regulation (EU) 2024/893 of 22 March 2024 approving thermally treated garlic juice as an existing active substance for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2024/917 of 22 March 2024 amending Implementing Regulation (EU) 2022/92 as regards certain reporting requirements for passively fished wasteCouncil Implementing Regulation (EU) 2024/952 of 22 March 2024 implementing Regulation (EU) 2020/1998 concerning restrictive measures against serious human rights violations and abusesCommission Implementing Regulation (EU) 2024/999 of 22 March 2024 entering a name in the register of protected designations of origin and protected geographical indications [Abricot des Baronnies (PGI)]Commission Implementing Regulation (EU) 2024/875 of 21 March 2024 adopting a list of abbreviations and pictograms common throughout the Union to be used on the packaging of veterinary medicinal products for the purposes of Article 10(2) and Article 11(3) of Regulation (EU) 2019/6 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2024/877 of 21 March 2024 amending Annex VIII to Regulation (EC) No 999/2001 of the European Parliament and of the Council as regards the approval of the negligible risk status for classical scrapie of CzechiaCommission Implementing Regulation (EU) 2024/878 of 21 March 2024 adopting uniform rules on the size of small immediate packaging units of veterinary medicinal products as referred to in Article 12 of Regulation (EU) 2019/6 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2024/879 of 21 March 2024 amending Implementing Regulation (EU) 2018/2019 as regards certain plants for planting of Corylus avellana, originating in the United KingdomCommission Implementing Regulation (EU) 2024/883 of 21 March 2024 amending Implementing Regulation (EU) 2021/535 as regards the second rear registration plate space for trailers and the mass of energy storage systems and correcting that RegulationCommission Implementing Regulation (EU) 2024/964 of 21 March 2024 concerning the classification of certain goods in the Combined Nomenclature

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next